PATENT CLAIM ANALYSIS

Application Number: 16011432
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["548", "302400"]

Abstract:
The present disclosure provides novel compounds capable of functioning as inhibitors of the kynurenine pathway and kits.

Claim (Index 1):
A compound comprising a structure of Structure I: including pharmaceutically acceptable solvates, pharmaceutically acceptable prodrugs, pharmaceutically acceptable salts and pharmaceutically acceptable stereoisomers thereof, wherein: R 1 -R 3  are each independently selected from the group consisting of hydrogen, halogen (e.g. F, Cl, Br, and I), haloalkyl (e.g. CF 3 ), and methyl; R 4  are each independently selected from the group consisting of hydrogen and methyl; X is \u2014(CH 2 ) n \u2014, wherein, n is 1, 2, or 3; and R 5  is independently selected from the group consisting of halogen (e.g. F, Cl, Br, and I), haloalkyl (e.g. CF 3 ), methyl (\u2014CH 3 ), cyano (\u2014CN), ethynyl (\u2014CCH), and methoxy (\u2014OCH 3 ).

Metadata:
- Claim Count in Document: 1.0
- Percentile: 94.0
- Lexical Diversity: 1.05882
- Patent Class: 548.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14774383', '15724596', '15564666', '15713502', '14711911']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6361856565847097
- 35 USC 102 Novelty (BERT): 0.4572748786412601
- Combined Prediction Score: 0.6182945787903649
- Mean Citation Score: 115.47017
- Max Citation Score: 126.57186000000002
- Similarity Product: 100.53553297479272

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test